Company intelligence / Profile preview

HLB Life Science Co., Ltd.

Hwaseong-si or Sejong City, Gyeonggi-do / Sejong Special Self-Governing City, SOUTH KOREAhlbkorea.com ↗

Ownership: Private
Employees: ~145
Development stage: NDA

Overview

HLB Life Science focuses on developing innovative anti-cancer drugs and in vitro diagnostic products. Its lead asset Rivoceranib targets VEGFR2 and has been studied in multiple solid tumor indications. The company also develops Pyrotinib for HER-family positive cancers. In addition to oncology therapeutics and diagnostics/devices for women’s health and general disease prevention/monitoring using advanced nanomaterials. The company commercializes several products domestically and internationally.

Therapeutic areas: OncologyWomen's Health
Modalities: Small molecules (e.g. tyrosine kinase inhibitors)diagnostic devicesnanoparticles (Graphene, Carbon Nanotube, Magnetic Beads)medical devices for women's health
Industry: Biotech

Drug pipeline

2 assets

rivoceranib

NDA

Indications: Hepatocellular carcinoma, Gastric cancer, Adenoid cystic carcinoma

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on HLB Life Science Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HLB Life Science Co., Ltd..

Explore the full profile